Sen. Herb Kohl says major firms fear retaliation from Express Scripts (ESRX) and Medco Health...


Sen. Herb Kohl says major firms fear retaliation from Express Scripts (ESRX) and Medco Health (MHS) if they speak out at a DC hearing to criticize the proposed merger (I, II). Other Senators joined Kohl in railing against the union, which they argue would create a PBM giant controlling 60% of the mail order prescription business and 50% of the specialty drug market. Still on tap for the ESRX-MHS deal: Reaching an agreement with the FTC and keeping a bevvy of state attorneys general off their back.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs